Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 992 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its valuation, institutional ownership, dividends, analyst recommendations, risk, profitability and earnings. Insider & Institutional Ownership 21.1% […]